← Back
$VRTX All transactions

VERTEX PHARMACEUTICALS INC / MA

A

$ Value

$0

Shares

2,950

Price

$0

Filed

Jan 26

Insider

Name

Ambrose Kristen

Title

SVP & Chief Accounting Officer

CIK

0001856587

Roles

Officer

Transaction Details

Transaction Date

2026-01-22

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,795

Footnotes

Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest on 02/13/2026. | Represents earned performance shares with respect to a performance stock unit award granted on 02/12/2025 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest in installments beginning on 02/24/2026.

Filing Info

Accession No.

0001856587-26-000002

Form Type

4

Issuer CIK

0000875320

Ambrose Kristen's History

Date Ticker Type Value
2026-01-22 VRTX A $0
2026-01-22 VRTX A $0

Other Insiders at VRTX (90d)

Insider Bought Sold Last
SACHS BRUCE I 2026-04-15
WAGNER CHARLES F JR
EVP, CO & FO
2026-01-22
LEIDEN JEFFREY M
Executive Chairman
2026-01-22
Garber Alan M 2026-04-15
Sachdev Amit
EVP Chief Patient & Ext Af Off
2026-01-22
Upadhyay Suketu 2026-04-15
ALTSHULER DAVID
EVP, Chief Scientific Officer
2026-01-22
Kewalramani Reshma
CEO & President
2026-01-22
Biller Jonathan
EVP and Chief Legal Officer
2026-01-22
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
2026-01-22
Bozic Carmen
EVP and CMO
$1.1M 2026-03-27
Liu Joy
EVP and Chief Legal Officer
$439K 2026-04-01
Ambrose Kristen
SVP & Chief Accounting Officer
2026-01-22
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
2026-01-22
McKechnie Duncan
EVP, Chief Commercial Officer
2026-01-22